ENCEFALOPATIA EPATICA: UNA GRANDE META-ANALISI 2022 DALLA PARTE DEL PAZIENTE! LATTULOSIO O RIFAXIMINA? DA “AMERICAN JOURNAL OF GASTROENTEROLOGY”
Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy Andrew M. Moon et al INTRODUCTION: Patients with hepatic encephalopathy (HE) suffer from significant symptoms and impaired quality of life. Improved understanding on the potential benefits of first-line HE therapies may aid patientprovider discussions regarding expected benefits of…
